Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique

Por Kusters, Miranda, Uehara, Keisuke, Velde, Cornelis J. H. van de, Moriya, Yoshihiro
Publicado no Clin Colon Rectal Surg (2017)

A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case repo...

Por Uji, Masahito, Mizuno, Takashi, Ebata, Tomoki, Sugawara, Gen, Igami, Tsuyoshi, Uehara, Keisuke, Nagino, Masato
Publicado no Surg Case Rep (2016)

SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer

Por Mansour, Mohammed A., Hyodo, Toshinori, Akter, Khondker Ayesha, Kokuryo, Toshio, Uehara, Keisuke, Nagino, Masato, Senga, Takeshi
Publicado no Oncotarget (2015)

Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection

Por Utsunomiya, Setsuo, Uehara, Keisuke, Kurimoto, Takuya, Hirose, Ken, Fukaya, Masahide, Takahashi, Yu, Taguchi, Yoshiro, Itatsu, Keita, Nagino, Masato
Publicado em 2013

Adenocarcinoma Arising from Sacrococcygeal Mature Teratoma in an Adult Female: Report of a Case

Por Matsumoto, Naoki, Uehara, Keisuke, Ando, Masataka, Arimoto, Junki, Kato, Takehiro, Nakamura, Hayato, Ebata, Tomoki, Yokoyama, Yukihiro, Nagino, Masato
Publicado em 2014

TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion

Por Kurita, Kenji, Maeda, Masao, Mansour, Mohammed A., Kokuryo, Toshio, Uehara, Keisuke, Yokoyama, Yukihiro, Nagino, Masato, Hamaguchi, Michinari, Senga, Takeshi
Publicado no Oncol Lett (2016)

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial

Por Yoshimura Kenichi, Uehara Keisuke, Tojima Yuichiro, Kawai Satoru, Mokuno Yasuji, Maeda Atsuyuki, Kyokane Takanori, Kobayashi Satoshi, Yoshioka Yuichiro, Nagino Masato
Publicado em 2013-01-01

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial

Por Yoshimura, Kenichi, Uehara, Keisuke, Tojima, Yuichiro, Kawai, Satoru, Mokuno, Yasuji, Maeda, Atsuyuki, Kyokane, Takanori, Kobayashi, Satoshi, Yoshioka, Yuichiro, Nagino, Masato
Publicado em 2013

Limited Internal Radiation Exposure Associated with Resettlements to a Radiation-Contaminated Homeland after the Fukushima Daiichi Nuclear Disaster

Por Tsubokura, Masaharu, Kato, Shigeaki, Nihei, Masahiko, Sakuma, Yu, Furutani, Tomoyuki, Uehara, Keisuke, Sugimoto, Amina, Nomura, Shuhei, Hayano, Ryugo, Kami, Masahiro, Watanobe, Hajime, Endo, Yukou
Publicado em 2013

The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multic...

Por Nakayama, Goro, Uehara, Keisuke, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Ishiyama, Akiharu, Eguchi, Takehiko, Tsuboi, Kenji, Ohashi, Norifumi, Fujii, Tsutomu, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Ando, Yuich, Kodera, Yasuhiro
Publicado em 2012

Modified two‐dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer

Por Nakayama, Goro, Fujii, Tsutomu, Murotani, Kenta, Uehara, Keisuke, Hattori, Norifumi, Hayashi, Masamichi, Tanaka, Chie, Kobayashi, Daisuke, Kanda, Mitsuro, Yamada, Suguru, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Ando, Yuichi, Kodera, Yasuhiro
Publicado no Cancer Sci (2016)

A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial)

Por Ishihara, Soichiro, Matsusaka, Satoshi, Kondo, Keisaku, Horie, Hisanaga, Uehara, Keisuke, Oguchi, Masahiko, Murofushi, Keiko, Ueno, Masashi, Mizunuma, Nobuyuki, Shinbo, Taijyu, Kato, Daiki, Okuda, Junji, Hashiguchi, Yojiro, Nakazawa, Masanori, Sunami, Eiji, Kawai, Kazushige, Yamashita, Hideomi, Okada, Tohru, Ishikawa, Yuichi, Nakajima, Toshifusa, Watanabe, Toshiaki
Publicado no Radiat Oncol (2015)

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-cent...

Por Nakayama, Goro, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Uehara, Keisuke, Kojima, Hiroshi, Ishiyama, Akiharu, Hayashi, Naomi, Takano, Nao, Hattori, Norifumi, Kobayashi, Daisuke, Tanaka, Chie, Hayashi, Masamichi, Kanda, Mitsuro, Yamada, Suguru, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Fujii, Tsutomu, Murotani, Kenta, Ando, Yuichi, Kodera, Yasuhiro
Publicado no BMC Cancer (2017)

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer

Por Watanabe, Toshiaki, Muro, Kei, Ajioka, Yoichi, Hashiguchi, Yojiro, Ito, Yoshinori, Saito, Yutaka, Hamaguchi, Tetsuya, Ishida, Hideyuki, Ishiguro, Megumi, Ishihara, Soichiro, Kanemitsu, Yukihide, Kawano, Hiroshi, Kinugasa, Yusuke, Kokudo, Norihiro, Murofushi, Keiko, Nakajima, Takako, Oka, Shiro, Sakai, Yoshiharu, Tsuji, Akihito, Uehara, Keisuke, Ueno, Hideki, Yamazaki, Kentaro, Yoshida, Masahiro, Yoshino, Takayuki, Boku, Narikazu, Fujimori, Takahiro, Itabashi, Michio, Koinuma, Nobuo, Morita, Takayuki, Nishimura, Genichi, Sakata, Yuh, Shimada, Yasuhiro, Takahashi, Keiichi, Tanaka, Shinji, Tsuruta, Osamu, Yamaguchi, Toshiharu, Yamaguchi, Naohiko, Tanaka, Toshiaki, Kotake, Kenjiro, Sugihara, Kenichi
Publicado no Int J Clin Oncol (2017)